Dr Stavroula Nanaki is a guest editor on the Special Issue on Glaucoma, in the journal Applied Sciences.
"Glaucoma is a disease caused when pressure builds up inside the eye, damaging the optic nerve that connects the eye to the brain. If it is not treated in time, it can cause irreversible blindness. It is responsible for the loss of vision of 4.5 million people across the globe, a parameter that renders glaucoma the third highest cause of blindness worldwide. Treatment of glaucoma is comp
osed of drug formulations and/or surgery. This Special Issue aims to cover all aspects of innovative drug delivery systems for the treatment of glaucoma. Special emphasis will be placed on novel polymeric matrices, organic and inorganic nanoparticles, and formulations consisting of eye drops, gels, and contact lenses. We also intend to include antibody formulations in this Special Issue. In vitro and/or in vivo experiments concerning drug formulations will also be accepted. Finally, we would like to emphasize that this Special Issue is widely inclusive
, so we expect a large number of works to fall within its scope.
Dr. Stavroula Nanaki"
Deadline for manuscript submissions: 30 June 2020.
To submit your manuscript click here.
Comments